Stock Fundamentals

Company Information

Company Name
Dynavax Technologies Corporation
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US2681582019
CIK: 0001029142
CUSIP: 268158102
Currency: USD
Full Time Employees: 405
Phone: 510 848 5100
Fiscal Year End: December
IPO Date: Feb 19, 2004
Description:

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Address:

2100 Powell Street, EmeryVille, CA, United States, 94608

Directors & Officers

Name Title Year Born
Mr. Ryan Spencer CEO & Director 1979
Ms. Kelly MacDonald CPA Senior VP & CFO 1984
Mr. David F. Novack Senior VP & COO 1962
Mr. John L. Slebir Esq. Senior VP & General Counsel 1965

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 15, 2026 David F Novack N/A Sale 114.00K $15.64 $1.78M
Dec 24, 2025 David F Novack N/A Sale 30.00K $15.49 $464.70K
Aug 22, 2025 Scott Dunseth Myers N/A Purchase 3.80K $10.82 $41.12K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 16.25M Sep 30, 2025 14.29% $0.00 -5.78%
Deep Track Capital, LP 15.73M Dec 31, 2025 13.83% $4.31 0.00%
Vanguard Group Inc 8.03M Dec 31, 2025 7.06% $0.00 -0.89%
State Street Corp 6.29M Sep 30, 2025 5.53% $0.00 -1.73%
Chicago Capital LLC 3.47M Dec 31, 2025 3.05% $1.32 -19.48%
Renaissance Technologies Corp 3.34M Dec 31, 2025 2.94% $0.08 6.34%
Dimensional Fund Advisors, Inc. 3.01M Dec 31, 2025 2.65% $0.01 -15.59%
Marshall Wace Asset Management Ltd 2.51M Dec 31, 2025 2.21% $0.04 23.27%
Geode Capital Management, LLC 2.42M Dec 31, 2025 2.12% $0.00 -4.56%
JPMorgan Chase & Co 1.94M Sep 30, 2025 1.71% $0.00 105.93%
Nuveen, LLC 1.91M Dec 31, 2025 1.68% $0.01 400.34%
The Goldman Sachs Group Inc 1.86M Sep 30, 2025 1.64% $0.00 13.41%
Blair William & Co 1.78M Dec 31, 2025 1.57% $0.07 -20.06%
Morgan Stanley - Brokerage Accounts 1.66M Sep 30, 2025 1.46% $0.00 -0.34%
Two Sigma Investments LLC 1.63M Dec 31, 2025 1.44% $0.04 14.28%
Soros Fund Management LLC 1.57M Dec 31, 2025 1.38% $0.28 0.00%
Sand Grove Capital Management LLP 1.53M Dec 31, 2025 1.34% $7.97 0.00%
Bank of America Corp 1.46M Sep 30, 2025 1.28% $0.00 25.70%
Kynam Capital Management, LP 1.38M Dec 31, 2025 1.21% $1.35 -35.88%
Two Sigma Advisers, LLC 1.32M Dec 31, 2025 1.16% $0.04 -16.68%

Shares Statistics

Shares Outstanding: 113.68M
Shares Float: 100.34M
% Insiders: 75.30%
% Institutions: 10,154.50%
Short % Float: 13.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Glenmede Small Cap Equity Adv 1.05M 0.92% ▼ 8.49% Dec 31, 2025
2 Glenmede Small Cap Equity 1.05M 0.92% ▼ 8.49% Dec 31, 2025
3 Fidelity Small Cap Index 986.14K 0.87% ▼ 4.87% Dec 31, 2025
4 iShares S&P Small-Cap 600 Value ETF 968.63K 0.85% ▲ 0.00% Feb 09, 2026
5 Rhenman Healthcare Equity L/S RC2 SEK 772.00K 0.68% ▲ 0.00% Nov 30, 2025
6 Nuveen Quant Small Cap Equity R6 719.91K 0.63% ▲ 0.00% Jan 31, 2026
7 DFA US Small Cap I 592.72K 0.52% ▲ 0.00% Jan 31, 2026
8 Nomura Healthcare Fund Class I 570.00K 0.50% ▲ 0.00% Jan 31, 2026
9 Fidelity Extended Market Index 524.76K 0.46% ▼ 0.41% Jan 31, 2026
10 CREF Total Global Stock Account R3 441.89K 0.39% ▼ 4.88% Jan 31, 2026

Valuation Metrics

Enterprise Value: $1.40B
Trailing P/E: 0.00
Forward P/E: 29.24

Financial Highlights

Market Cap: $1.82B
EBITDA: $24.21M
PEG Ratio: $0.00
Book Value: $4.55
Earnings/Share: $-0.37
Profit Margin: -13.13%
Operating Margin: 24.77%
ROA (TTM): 1.20%
ROE (TTM): -7.14%
Revenue (TTM): $330.51M
Revenue/Share (TTM): $2.70
Earnings Growth (YOY): 69.30%
Revenue Growth (YOY): 17.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 10.80x 0.38x 0.39x -0.61x 4.99x
2023-12-31 13.81x 0.37x 0.38x -5.48x 23.50x
2022-12-31 6.11x 0.39x 0.41x 42.12x 0.73x
2021-12-31 1.75x 1.00x 0.79x 12.03x 2.33x
2020-12-31 3.75x 3.12x 0.83x -3.95x -3.91x
2019-12-31 3.93x 21.91x 0.97x -7.94x -1.59x
2018-12-31 4.33x 1.60x 0.70x -16.42x -0.75x
2017-12-31 10.32x 0.00x 0.09x N/A 0.00x
2016-12-31 4.06x 0.00x 0.19x -193.54x 0.00x
2015-12-31 6.81x 0.00x 0.14x -183.69x 0.00x
2014-12-31 6.05x 0.12x 0.27x -2,608.89x -0.13x
2013-12-31 11.88x 0.04x 0.09x N/A -0.12x
2012-12-31 6.58x 0.08x 0.18x -28.75x -0.15x
2011-12-31 4.58x 0.13x 0.26x -24.31x -0.28x
2010-12-31 5.07x 0.21x 0.38x -28.77x -0.21x
2009-12-31 2.69x 2.64x 0.87x -121.90x -1.38x
2008-12-31 1.87x 0.00x 0.82x -2.63x 0.00x
2007-12-31 5.12x 0.00x 0.68x -41.36x 0.00x
2006-12-31 6.55x 0.00x 0.23x N/A 0.00x
2005-12-31 13.98x 0.00x 0.07x N/A 0.00x
2004-12-31 10.47x 0.00x 0.19x N/A 0.00x
2003-12-31 5.97x 0.00x 2.81x N/A 0.00x
2002-12-31 7.15x 0.00x 2.79x N/A 0.00x
2001-12-31 0.00x 0.00x 3.28x N/A 0.00x
2000-12-31 N/A 0.00x 1.61x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DVAX.US!